Company Valuation: CARE Ratings Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 15,133 19,092 33,416 33,105 43,523 50,314 - -
Change - 26.16% 75.03% -0.93% 31.47% 15.6% - -
Enterprise Value (EV) 15,133 19,092 33,416 33,105 43,523 50,314 50,314 50,314
Change - 26.16% 75.03% -0.93% 31.47% 15.6% 0% 0%
P/E 20.2x 22.8x 33.2x 24.2x 25.5x 24.9x 21.5x 18.7x
PBR 2.34x 2.67x 4.61x 4.07x 4.68x 4.67x 4.07x 3.55x
PEG - 2x 1.7x 0.7x 1x 1.4x 1.4x 1.3x
Capitalization / Revenue 6.11x 6.68x 10.1x 8.23x 9.2x 9.07x 7.89x 6.91x
EV / Revenue 0x 0x 0x 0x 0x 9.07x 7.89x 6.91x
EV / EBITDA 0x 0x 0x 0x 0x 21.9x 18.7x 16.3x
EV / EBIT 0x 0x 0x 0x 0x 23.6x 20.1x 17.5x
EV / FCF 0x 0x 0x 0x 0x 22.4x 19.5x 17x
FCF Yield 3.24% 3.71% 2.45% 3.27% 3.2% 4.46% 5.12% 5.87%
Dividend per Share 2 17 17 17 18 14 26.1 28.5 32.5
Rate of return 3.33% 2.64% 1.52% 1.63% 0.97% 1.56% 1.7% 1.94%
EPS 2 25.31 28.17 33.67 45.69 56.83 67.2 77.9 89.5
Distribution rate 67.2% 60.3% 50.5% 39.4% 24.6% 38.8% 36.6% 36.3%
Net sales 1 2,476 2,859 3,317 4,023 4,731 5,545 6,378 7,281
EBITDA 1 798.2 993.4 1,121 1,553 1,974 2,300 2,691 3,092
EBIT 1 721.2 945.2 1,017 1,436 1,830 2,136 2,501 2,869
Net income 1 751.1 835.3 1,005 1,372 1,712 2,021 2,341 2,689
Net Debt - - - - - - - -
Reference price 2 510.45 642.80 1,119.40 1,106.00 1,448.50 1,674.40 1,674.40 1,674.40
Nbr of stocks (in thousands) 29,647 29,701 29,852 29,932 30,047 30,049 - -
Announcement Date 5/29/22 5/11/23 5/9/24 5/12/25 5/13/26 - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
24.92x - - 1.56% 526M
30.94x11.15x20.92x0.83% 87.17B
35.28x - - 1.68% 3.45B
25.59x - - 1.59% 499M
Average 29.18x 11.15x 20.92x 1.41% 22.91B
Weighted average by Cap. 31.04x 11.15x 20.92x 0.87%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. CARERATING Stock
  4. Valuation CARE Ratings Limited